1 |
13 valent conjugated pneumococcal vaccine |
- |
- |
- |
- |
265 1件: 265 💬 |
2 |
150 mg gsk1265744b |
- |
- |
- |
- |
265 1件: 265 💬 |
3 |
300mg gemcabene |
Gemcabene |
- |
- |
- |
265 1件: 265 💬 |
4 |
3tc |
- |
- |
- |
- |
265 1件: 265 💬 |
5 |
600mg gemcabene |
Gemcabene |
- |
- |
- |
265 1件: 265 💬 |
6 |
[n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate |
Acetate |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
265 1件: 265 💬 |
7 |
Abacavir |
Abacavir |
2件: D00891 D00891, D07057 D07057 💬 |
- |
- |
135 3件: 135, 265, 325 💬 |
8 |
Abacavir 300mg twice daily |
Abacavir |
2件: D00891 D00891, D07057 D07057 💬 |
- |
- |
265 1件: 265 💬 |
9 |
Abacavir sulfate |
Abacavir |
2件: D00891 D00891, D07057 D07057 💬 |
- |
- |
265 1件: 265 💬 |
10 |
Abacavir sulfate, lamivudine and zidovudine |
Abacavir |
4件: D00353 D00353, D00413 D00413, D00891 D00891, D07057 D07057 💬 |
- |
- |
265 1件: 265 💬 |
11 |
Abc |
- |
- |
- |
- |
265 1件: 265 💬 |
12 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
13 |
Acetyl- l- carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
265 1件: 265 💬 |
14 |
Acetylcarnitine |
Acetylcarnitine |
- |
- |
- |
002 2件: 2 , 265 💬 |
15 |
Acipimox |
Acipimox |
1件: D07190 D07190 💬 |
- |
- |
078 2件: 78, 265 💬 |
16 |
Akcea-angptl3-lrx |
- |
- |
- |
- |
079 2件: 79, 265 💬 |
17 |
Amprenavir |
Amprenavir |
1件: D00894 D00894 💬 |
- |
- |
265 1件: 265 💬 |
18 |
Antiretroviral/anti hiv |
- |
- |
- |
- |
265 1件: 265 💬 |
19 |
Aramchol |
Aramchol |
- |
- |
- |
265 1件: 265 💬 |
20 |
Atazanavir |
Atazanavir |
2件: D01276 D01276, D07471 D07471 💬 |
- |
- |
265 1件: 265 💬 |
21 |
Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) |
Atazanavir |
3件: D00427 D00427, D01276 D01276, D07471 D07471 💬 |
- |
- |
265 1件: 265 💬 |
22 |
Atazanavir (reyataz) |
Atazanavir |
2件: D01276 D01276, D07471 D07471 💬 |
- |
- |
265 1件: 265 💬 |
23 |
Atazanavir/ritonavir |
Atazanavir |
3件: D00427 D00427, D01276 D01276, D07471 D07471 💬 |
- |
- |
265 1件: 265 💬 |
24 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
25 |
Atorvastatin calcium |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
265 1件: 265 💬 |
26 |
Atv |
- |
- |
- |
- |
265 1件: 265 💬 |
27 |
Avandia administration for 6-12 weeks |
- |
- |
- |
- |
265 1件: 265 💬 |
28 |
Azt |
- |
- |
- |
- |
094 2件: 94, 265 💬 |
29 |
Azt/3tc |
- |
- |
- |
- |
265 1件: 265 💬 |
30 |
Baricitinib |
Baricitinib |
1件: D10308 D10308 💬 |
JAK1 2件: JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
31 |
Behavioral: 60-minutes of steady state exercise |
- |
- |
- |
- |
265 1件: 265 💬 |
32 |
Behavioral: diet |
- |
- |
- |
- |
265 1件: 265 💬 |
33 |
Behavioral: exercise |
- |
- |
- |
- |
006 3件: 6 , 265, 299 💬 |
34 |
Behavioral: exercise training |
- |
- |
- |
- |
265 1件: 265 💬 |
35 |
Bms-232632 |
- |
- |
- |
- |
265 1件: 265 💬 |
36 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
37 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
38 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
39 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265 💬 |
40 |
Cd-4 guided therapy interruption |
- |
- |
- |
- |
265 1件: 265 💬 |
41 |
Cholic acid |
Cholic Acid |
1件: D10699 D10699 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 234, 265, 310 💬 |
42 |
Cofactor |
- |
- |
- |
- |
006 3件: 6 , 265, 288 💬 |
43 |
Cofactor supplementation (thiamine, riboflavin, l-carnitine) |
Levocarnitine |
7件: D00050 D00050, D01622 D01622, D01913 D01913, D02030 D02030, D02176 D02176, D04713 D04713, D08580 D08580 💬 |
- |
- |
265 1件: 265 💬 |
44 |
Combivir |
- |
- |
- |
- |
265 1件: 265 💬 |
45 |
Combivir (zidovudine [azt] / lamivudine [3tc]) |
Lamivudine |
2件: D00353 D00353, D00413 D00413 💬 |
- |
- |
265 1件: 265 💬 |
46 |
Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) |
- |
- |
- |
- |
265 1件: 265 💬 |
47 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
48 |
Device: poly-l-lactic acid |
L-Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 1件: 265 💬 |
49 |
Device: venus versa |
- |
- |
- |
- |
265 1件: 265 💬 |
50 |
Didanosine |
Didanosine |
1件: D00296 D00296 💬 |
- |
- |
025 2件: 25, 265 💬 |
51 |
Different haart regimens |
- |
- |
- |
- |
265 1件: 265 💬 |
52 |
Diosmin |
Diosmin |
1件: D07858 D07858 💬 |
- |
- |
265 1件: 265 💬 |
53 |
Diosminex, 500 mg, tabletki powlekane |
- |
- |
- |
- |
265 1件: 265 💬 |
54 |
Dolutegravir |
Dolutegravir |
1件: D10066 D10066 💬 |
- |
- |
002 2件: 2 , 265 💬 |
55 |
Dolutegravir 50 mg |
Dolutegravir |
1件: D10066 D10066 💬 |
- |
- |
265 1件: 265 💬 |
56 |
Efavirenz |
Efavirenz |
1件: D00896 D00896 💬 |
- |
- |
265 1件: 265 💬 |
57 |
Efavirenz (efv) |
Efavirenz |
1件: D00896 D00896 💬 |
- |
- |
265 1件: 265 💬 |
58 |
Emtricitabine |
Emtricitabine |
1件: D01199 D01199 💬 |
- |
- |
025 4件: 25, 93, 265, 325 💬 |
59 |
Emtricitabine/tenofovir |
Emtricitabine |
2件: D01199 D01199, D06074 D06074 💬 |
- |
- |
265 1件: 265 💬 |
60 |
Enfuvirtide |
Enfuvirtide |
1件: D02499 D02499 💬 |
- |
- |
025 2件: 25, 265 💬 |
61 |
Enfuvirtide (t20) |
Enfuvirtide |
1件: D02499 D02499 💬 |
- |
- |
265 1件: 265 💬 |
62 |
Fenofibrate |
Fenofibrate |
1件: D00565 D00565 💬 |
PPARA 1件: PPARA 💬 |
Adipocytokine signaling pathway 8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
008 5件: 8 , 79, 93, 94, 265 💬 |
63 |
Gemcabene |
Gemcabene |
- |
- |
- |
079 2件: 79, 265 💬 |
64 |
Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene |
- |
- |
- |
- |
265 1件: 265 💬 |
65 |
Genotropin (human recombinant growth hormone) |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
265 1件: 265 💬 |
66 |
Glycerine |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
265 1件: 265 💬 |
67 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
68 |
Growth hormone releasing hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
265 1件: 265 💬 |
69 |
Gsk1265744b (sodium salt) containing 14c-gsk1265744b |
- |
- |
- |
- |
265 1件: 265 💬 |
70 |
High-carbohdyrate breakfast |
- |
- |
- |
- |
265 1件: 265 💬 |
71 |
High-dose regn4461 |
- |
- |
- |
- |
265 1件: 265 💬 |
72 |
Hu leptin (a-100) |
Leptin |
- |
- |
- |
265 1件: 265 💬 |
73 |
Human growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 4件: 78, 187, 193, 265 💬 |
74 |
Human recombinant leptin (metreleptin) |
Leptin |
1件: D05014 D05014 💬 |
LEPR 1件: LEPR 💬 |
AMPK signaling pathway 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease |
265 1件: 265 💬 |
75 |
Indinavir |
Indinavir |
3件: D00897 D00897, D02861 D02861, D03833 D03833 💬 |
- |
- |
265 1件: 265 💬 |
76 |
Isis 304801 |
- |
- |
- |
- |
265 1件: 265 💬 |
77 |
Kaletra (lopinavir [lpvr]) |
Lopinavir |
1件: D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
78 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
79 |
L-lactic acid |
L-Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 1件: 265 💬 |
80 |
Lactic acid |
Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 2件: 265, 299 💬 |
81 |
Lamivudine |
Lamivudine |
1件: D00353 D00353 💬 |
- |
- |
026 6件: 26, 42, 46, 135, 265, 325 💬 |
82 |
Lamivudine/zidovudine |
Lamivudine |
2件: D00353 D00353, D00413 D00413 💬 |
- |
- |
265 1件: 265 💬 |
83 |
Leptin |
Leptin |
- |
- |
- |
006 2件: 6 , 265 💬 |
84 |
Lopinavir |
Lopinavir |
1件: D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
85 |
Lopinavir/ritonavir |
Lopinavir |
2件: D00427 D00427, D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
86 |
Lopinavir/ritonavir + nevirapine |
Lopinavir |
3件: D00427 D00427, D00435 D00435, D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
87 |
Lopinavir/ritonavir + zidovudine + lamivudine |
Lamivudine |
4件: D00353 D00353, D00413 D00413, D00427 D00427, D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
88 |
Low-dose regn4461 |
- |
- |
- |
- |
265 1件: 265 💬 |
89 |
Mecasermin |
Mecasermin |
2件: D03297 D03297, D04870 D04870 💬 |
GHR 2件: GHR, IGF1R 💬 |
AMPK signaling pathway 33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 5件: 78, 96, 168, 265, 299 💬 |
90 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
91 |
Metformin hydrochloride |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
081 5件: 81, 158, 265, 299, 301 💬 |
92 |
Metreleptin |
Metreleptin |
1件: D05014 D05014 💬 |
LEPR 1件: LEPR 💬 |
AMPK signaling pathway 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease |
265 1件: 265 💬 |
93 |
Metrelpetin |
- |
- |
- |
- |
265 1件: 265 💬 |
94 |
Monotherapy (lopinavir/ritonavir) |
Lopinavir |
2件: D00427 D00427, D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
95 |
Monotherapy (lopinavir/ritonavir) + abc/3tc |
Lopinavir |
2件: D00427 D00427, D01425 D01425 💬 |
- |
- |
265 1件: 265 💬 |
96 |
Myalept |
- |
- |
- |
- |
265 1件: 265 💬 |
97 |
Nelfinavir |
Nelfinavir |
2件: D00899 D00899, D08259 D08259 💬 |
- |
- |
049 3件: 49, 265, 331 💬 |
98 |
Nelfinavir mesylate |
Nelfinavir |
2件: D00899 D00899, D08259 D08259 💬 |
- |
- |
265 1件: 265 💬 |
99 |
Nevirapine |
Nevirapine |
1件: D00435 D00435 💬 |
- |
- |
265 1件: 265 💬 |
100 |
Niacin |
Niacin |
1件: D00049 D00049 💬 |
- |
- |
006 3件: 6 , 78, 265 💬 |
101 |
Non-nucleoside reverse transcriptase inhibitors |
- |
- |
- |
- |
265 1件: 265 💬 |
102 |
Norvir |
- |
- |
- |
- |
265 2件: 265, 299 💬 |
103 |
Nucleomaxx |
- |
- |
- |
- |
265 1件: 265 💬 |
104 |
Nucleoside analogue sparing haart regimen |
- |
- |
- |
- |
265 1件: 265 💬 |
105 |
Nucleoside reverse transcriptase inhibitors |
- |
- |
- |
- |
265 1件: 265 💬 |
106 |
Obeticholic acid |
Obeticholic acid |
1件: D09360 D09360 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
093 3件: 93, 265, 296 💬 |
107 |
Other: glycerine gel |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
265 1件: 265 💬 |
108 |
Other: observation |
- |
- |
- |
- |
265 1件: 265 💬 |
109 |
Perform blood cells and fibroblasts biochemical and immuno-labeled investigations |
- |
- |
- |
- |
265 1件: 265 💬 |
110 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
111 |
Pioglitazone or metformin |
Metformin |
4件: D00944 D00944, D00945 D00945, D04966 D04966, D08378 D08378 💬 |
PPARG 3件: PPARG, PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 25件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway |
265 1件: 265 💬 |
112 |
Pneumococcal polysaccharide vaccine 23 valent |
- |
- |
- |
- |
265 1件: 265 💬 |
113 |
Poly-l-lactic acid |
L-Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 1件: 265 💬 |
114 |
Pravastatin |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
115 |
Pravastatin sodium |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
265 1件: 265 💬 |
116 |
Prevenar13 |
- |
- |
- |
- |
019 2件: 19, 265 💬 |
117 |
Procedure: testosterone injection |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
265 1件: 265 💬 |
118 |
Protease inhibitor |
- |
- |
- |
- |
265 1件: 265 💬 |
119 |
Protease inhibitors |
- |
- |
- |
- |
265 1件: 265 💬 |
120 |
R-methuleptin |
Metreleptin |
1件: D05014 D05014 💬 |
LEPR 1件: LEPR 💬 |
AMPK signaling pathway 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease |
265 1件: 265 💬 |
121 |
Raltegravir |
Raltegravir |
1件: D06676 D06676 💬 |
- |
- |
013 4件: 13, 26, 93, 265 💬 |
122 |
Recombinant human growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 3件: 78, 193, 265 💬 |
123 |
Recombinant human growth hormone + rosiglitazone |
Rosiglitazone |
3件: D00596 D00596, D02691 D02691, D08491 D08491 💬 |
GHR 2件: GHR, PPARG 💬 |
AMPK signaling pathway 14件: AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
265 1件: 265 💬 |
124 |
Reyataz |
- |
- |
- |
- |
265 1件: 265 💬 |
125 |
Reyataz 150mg 60 cps bl |
- |
- |
- |
- |
265 1件: 265 💬 |
126 |
Riboflavin |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
127 |
Ritonavir |
Ritonavir |
1件: D00427 D00427 💬 |
- |
- |
002 3件: 2 , 86, 265 💬 |
128 |
Ritonavir (norvir) |
Ritonavir |
1件: D00427 D00427 💬 |
- |
- |
265 1件: 265 💬 |
129 |
Rosiglitazone |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
130 |
Rosiglitazone maleate |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 3件: 46, 75, 265 💬 |
131 |
Rtv |
- |
- |
- |
- |
265 1件: 265 💬 |
132 |
Saquinavir |
Saquinavir |
2件: D00429 D00429, D01160 D01160 💬 |
- |
- |
086 2件: 86, 265 💬 |
133 |
Serostim®[somatropin (rdna origin) for injection] |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
265 1件: 265 💬 |
134 |
Setmelanotide |
Setmelanotide |
1件: D11927 D11927 💬 |
MC4R 1件: MC4R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
202 2件: 202, 265 💬 |
135 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
136 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
137 |
St200 |
- |
- |
- |
- |
265 1件: 265 💬 |
138 |
Standard continuous antiretroviral therapy |
- |
- |
- |
- |
265 1件: 265 💬 |
139 |
Stavudine |
Stavudine |
1件: D00445 D00445 💬 |
- |
- |
265 1件: 265 💬 |
140 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
141 |
Sustiva |
- |
- |
- |
- |
265 1件: 265 💬 |
142 |
Tat4 gel concentration a |
- |
- |
- |
- |
265 1件: 265 💬 |
143 |
Tat4 gel concentration b |
- |
- |
- |
- |
265 1件: 265 💬 |
144 |
Tenofovir |
Tenofovir |
1件: D06074 D06074 💬 |
- |
- |
002 5件: 2 , 25, 93, 265, 325 💬 |
145 |
Tenofovir df |
Tenofovir |
1件: D06074 D06074 💬 |
- |
- |
265 1件: 265 💬 |
146 |
Tenofovir disoproxil |
Tenofovir |
2件: D01982 D01982, D06074 D06074 💬 |
- |
- |
093 2件: 93, 265 💬 |
147 |
Tenofovir disoproxil fumarate |
Tenofovir |
2件: D01982 D01982, D06074 D06074 💬 |
- |
- |
265 1件: 265 💬 |
148 |
Tesamorelin |
Tesamorelin |
2件: D06655 D06655, D09015 D09015 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 2件: 78, 265 💬 |
149 |
Tesamorelin (egrifta) |
Tesamorelin |
2件: D06655 D06655, D09015 D09015 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
265 1件: 265 💬 |
150 |
Testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 8件: 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
151 |
Th9507 |
- |
- |
- |
- |
265 1件: 265 💬 |
152 |
Thiamine |
Thiamine |
1件: D08580 D08580 💬 |
- |
- |
008 3件: 8 , 13, 265 💬 |
153 |
Tipranavir |
Tipranavir |
2件: D03843 D03843, D08605 D08605 💬 |
- |
- |
265 1件: 265 💬 |
154 |
Total dietary replacement |
- |
- |
- |
- |
265 1件: 265 💬 |
155 |
Truvada |
- |
- |
- |
- |
265 1件: 265 💬 |
156 |
Use of lipid-lowering drugs. |
- |
- |
- |
- |
265 1件: 265 💬 |
157 |
Viral load driven treatment interruption |
- |
- |
- |
- |
265 1件: 265 💬 |
158 |
Volanesorsen |
Volanesorsen |
1件: D11648 D11648 💬 |
APOC3 1件: APOC3 💬 |
Cholesterol metabolism 2件: Cholesterol metabolism, PPAR signaling pathway |
265 1件: 265 💬 |
159 |
Volanesorsen sodium, apoc-iii antisense oligonucleotide |
Volanesorsen |
1件: D11648 D11648 💬 |
APOC3 1件: APOC3 💬 |
Cholesterol metabolism 2件: Cholesterol metabolism, PPAR signaling pathway |
265 1件: 265 💬 |
160 |
Zidovudine |
Zidovudine |
1件: D00413 D00413 💬 |
- |
- |
025 6件: 25, 26, 135, 265, 325, 331 💬 |